Your browser doesn't support javascript.
loading
X-Chromosome Association Study in Latin American Cohorts Identifies New Loci in Parkinson's Disease.
Leal, Thiago P; Rao, Shilpa C; French-Kwawu, Jennifer N; Gouveia, Mateus H; Borda, Victor; Bandres-Ciga, Sara; Inca-Martinez, Miguel; Mason, Emily A; Horimoto, Andrea R V R; Loesch, Douglas P; Sarihan, Elif I; Cornejo-Olivas, Mario R; Torres, Luis E; Mazzetti-Soler, Pilar E; Cosentino, Carlos; Sarapura-Castro, Elison H; Rivera-Valdivia, Andrea; Medina, Angel C; Dieguez, Elena M; Raggio, Víctor E; Lescano, Andrés; Tumas, Vitor; Borges, Vanderci; Ferraz, Henrique B; Rieder, Carlos R; Schumacher Schuh, Artur; Santos-Lobato, Bruno L; Velez-Pardo, Carlos; Jimenez-Del-Rio, Marlene; Lopera, Francisco; Moreno, Sonia; Chana-Cuevas, Pedro; Fernandez, William; Arboleda, Gonzalo; Arboleda, Humberto; Arboleda Bustos, Carlos E; Yearout, Dora; Barbosa, Maira T; Cardoso, Francisco E C; Caramelli, Paulo; Cunningham, Mauro C Q; Maia, Débora P; Lima-Costa, Maria F; Tarazona-Santos, Eduardo; Zabetian, Cyrus P; Thornton, Timothy A; O'Connor, Timothy D; Mata, Ignacio F.
Affiliation
  • Leal TP; Lerner Research Institute, Genomic Medicine, Cleveland Clinic, Cleveland, Ohio, USA.
  • Rao SC; The Parkinson's Foundation, Miami, Florida, USA.
  • French-Kwawu JN; Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Gouveia MH; Center for Research on Genomics and Global Health, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Borda V; Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Bandres-Ciga S; Center for Alzheimer's and Related Dementias, National Institutes of Health, Bethesda, Maryland, USA.
  • Inca-Martinez M; Lerner Research Institute, Genomic Medicine, Cleveland Clinic, Cleveland, Ohio, USA.
  • Mason EA; University of South Carolina School of Medicine, Columbia, South Carolina, USA.
  • Horimoto ARVR; Division of Aging, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Loesch DP; Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Sarihan EI; Lerner Research Institute, Genomic Medicine, Cleveland Clinic, Cleveland, Ohio, USA.
  • Cornejo-Olivas MR; Neurogenetics Working Group, Universidad Científica del Sur, Lima, Peru.
  • Torres LE; Neurogenetics Research Center, Instituto Nacional de Ciencias Neurologicas, Lima, Peru.
  • Mazzetti-Soler PE; Movement Disorders Unit, Instituto Nacional de Ciencias Neurologicas, Lima, Peru.
  • Cosentino C; Neurogenetics Research Center, Instituto Nacional de Ciencias Neurologicas, Lima, Peru.
  • Sarapura-Castro EH; Departamento de Medicina Humana, Universidad Nacional Mayor de San Marcos, Lima, Peru.
  • Rivera-Valdivia A; Movement Disorders Unit, Instituto Nacional de Ciencias Neurologicas, Lima, Peru.
  • Medina AC; Neurogenetics Research Center, Instituto Nacional de Ciencias Neurologicas, Lima, Peru.
  • Dieguez EM; Neurogenetics Research Center, Instituto Nacional de Ciencias Neurologicas, Lima, Peru.
  • Raggio VE; Universidad Nacional del Altiplano, Puno, Peru.
  • Lescano A; Neurology Institute, Universidad de la República, Montevideo, Uruguay.
  • Tumas V; Department of Genetics, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay.
  • Borges V; Neurology Institute, Universidad de la República, Montevideo, Uruguay.
  • Ferraz HB; Ribeirão Preto Medical School, Universidade de São Paulo, Ribeirão Preto, Brazil.
  • Rieder CR; Movement Disorders Unit, Department of Neurology and Neurosurgery, Universidade Federal de São Paulo, São Paulo, Brazil.
  • Schumacher Schuh A; Movement Disorders Unit, Department of Neurology and Neurosurgery, Universidade Federal de São Paulo, São Paulo, Brazil.
  • Santos-Lobato BL; Departamento de Neurologia, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, Brazil.
  • Velez-Pardo C; Serviço de Neurologia, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
  • Jimenez-Del-Rio M; Departamento de Farmacologia, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
  • Lopera F; Instituto de Ciências da Saúde, Universidade Federal do Pará, Belém, Brazil.
  • Moreno S; Neuroscience Research Group, Medical Research Institute, Faculty of Medicine, Universidad de Antioquia, Medellín, Colombia.
  • Chana-Cuevas P; Neuroscience Research Group, Medical Research Institute, Faculty of Medicine, Universidad de Antioquia, Medellín, Colombia.
  • Fernandez W; Neuroscience Research Group, Medical Research Institute, Faculty of Medicine, Universidad de Antioquia, Medellín, Colombia.
  • Arboleda G; Neuroscience Research Group, Medical Research Institute, Faculty of Medicine, Universidad de Antioquia, Medellín, Colombia.
  • Arboleda H; CETRAM, Facultad de Ciencias Médicas, Universidad de Santiago de Chile, Santiago, Chile.
  • Arboleda Bustos CE; Neuroscience and Cell Death Research Groups, Medical School and Genetic Institute, Universidad Nacional de Colombia, Bogotá, Colombia.
  • Yearout D; Neuroscience and Cell Death Research Groups, Medical School and Genetic Institute, Universidad Nacional de Colombia, Bogotá, Colombia.
  • Barbosa MT; Neuroscience and Cell Death Research Groups, Medical School and Genetic Institute, Universidad Nacional de Colombia, Bogotá, Colombia.
  • Cardoso FEC; Neuroscience and Cell Death Research Groups, Medical School and Genetic Institute, Universidad Nacional de Colombia, Bogotá, Colombia.
  • Caramelli P; Veterans Affairs Puget Sound Health Care System, Seattle, Washington, USA.
  • Cunningham MCQ; Department of Neurology, University of Washington, Seattle, Washington, USA.
  • Maia DP; Behavioral and Cognitive Neurology Unit, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
  • Lima-Costa MF; Geriatric Medicine, Faculdade Ciências Médicas de Minas Gerais, Belo Horizonte, Brazil.
  • Tarazona-Santos E; Movement Disorders Unit, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
  • Zabetian CP; Behavioral and Cognitive Neurology Unit, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
  • Thornton TA; Movement Disorders Unit, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
  • O'Connor TD; Movement Disorders Unit, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
  • Mata IF; Instituto René Rachou da Fundação Oswaldo Cruz, Belo Horizonte, Brazil.
Mov Disord ; 38(9): 1625-1635, 2023 09.
Article in En | MEDLINE | ID: mdl-37469269
ABSTRACT

BACKGROUND:

Sex differences in Parkinson's disease (PD) risk are well-known. However, the role of sex chromosomes in the development and progression of PD is still unclear.

OBJECTIVE:

The objective of this study was to perform the first X-chromosome-wide association study for PD risk in a Latin American cohort.

METHODS:

We used data from three admixed cohorts (1) Latin American Research consortium on the Genetics of Parkinson's Disease (n = 1504) as discover cohort, and (2) Latino cohort from International Parkinson Disease Genomics Consortium (n = 155) and (3) Bambui Aging cohort (n = 1442) as replication cohorts. We also developed an X-chromosome framework specifically designed for admixed populations.

RESULTS:

We identified eight linkage disequilibrium regions associated with PD. We replicated one of these regions (top variant rs525496; discovery odds ratio [95% confidence interval] 0.60 [0.478-0.77], P = 3.13 × 10-5 replication odds ratio 0.60 [0.37-0.98], P = 0.04). rs5525496 is associated with multiple expression quantitative trait loci in brain and non-brain tissues, including RAB9B, H2BFM, TSMB15B, and GLRA4, but colocalization analysis suggests that rs5525496 may not mediate risk by expression of these genes. We also replicated a previous X-chromosome-wide association study finding (rs28602900), showing that this variant is associated with PD in non-European populations.

CONCLUSIONS:

Our results reinforce the importance of including X-chromosome and diverse populations in genetic studies. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Chromosomes, Human, X Type of study: Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Mov Disord Journal subject: NEUROLOGIA Year: 2023 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Chromosomes, Human, X Type of study: Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Mov Disord Journal subject: NEUROLOGIA Year: 2023 Document type: Article Affiliation country: